The effect of a non-intensive community-based lifestyle intervention on the prevalence of Metabolic Syndrome. The DEPLAN study in Greece

Hormones

Volumn 11, Issue 3, 2012, Pages 316-324

  Makrilakis, Konstantinos ^a   Grammatikou, Sofia ^a   Liatis, Stavros ^a   Kontogianni, Meropi ^b   Perrea, Despoina ^a   Dimosthenopoulos, Charilaos ^a   Poulia, Kalliopi Anna ^a   Katsilambros, Nicholas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Lifestyle intervention; Metabolic syndrome; Type 2 diabetes prevention

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; COMMUNITY BASED REHABILITATION; DIETARY INTAKE; DIETITIAN; DISEASE ASSOCIATION; FEMALE; GREECE; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84864851262     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1360     Document Type: Article

References (30)

1. Reaven GM, 1988 Banting lecture 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
2. Gami AS, Witt BJ, Howard DE, et al, 2007 Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.
3. Ford ES, Li C, Sattar N, 2008 Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31: 1898-1904.
4. Alberti KG, Zimmet PZ, 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
5. Balkau B, Charles MA, 1999 Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442-443.
6. Executive summary of the third report of the National Cholesterol Education Program (NCEP), 2001 Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 285: 2486-2497.
7. Alberti KG, Zimmet P, Shaw J, 2005 The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062
8. Grundy SM, Cleeman JI, Daniels SR, et al, 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
9. Alberti KG, Eckel RH, Grundy SM, et al, 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
10. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436.
11. Doupis J, Dimosthenopoulos C, Diamanti K, Perrea D, Katsilambros N, Makrilakis K, 2009 Metabolic syndrome and Mediterranean dietary pattern in a sample of young, male, Greek navy recruits. Nutr Metab Cardiovasc Dis 19: e7-8.
12. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al, 2004 Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 147: 106-112.
13. Orchard TJ, Temprosa M, Goldberg R, et al, 2005 The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142: 611-619.
14. Ford ES, Giles WH, Dietz WH, 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359.
15. Ford ES, Giles WH, Mokdad AH, 2004 Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449.
16. Ford ES, 2005 Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28: 2745-2749.
17. Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, et al, 2005 The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 7: 397-405.
18. Lioudaki E, Vrentzos GE, Mavrogeni H, et al, 2012 Prevalence of Metabolic Syndrome According to Different Definitions in a Hypertensive Population. Angiology 63: 39-47.
19. Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N, 2010 Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLA N study. Diabet Med 27: 459-465.
20. Saaristo T, Peltonen M, Lindstrom J, et al, 2005 Crosssectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2: 67-72.
21. Makrilakis K, Liatis S, Grammatikou S, et al, 2011 Validation of the Finnish Diabetes Risk Score Questionnaire (FINDRISC) to Screen for Undiagnosed Type 2 Diabetes, Dysglycaemia and the Metabolic Syndrome in Greece. Diabetes Metab 32: 144-151.
22. Schwartz PEH, Lindstrom J, Kissimova-Skarbeck K, et al, on behalf of the DE-PLAN project, 2008 The European perspective of Type 2 diabetes prevention: Diabetes in Europe-Prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 116: 167-172.
23. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al, 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350.
24. World Medical Association declaration of Helsinki 1997 Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277: 925-926.
25. Kontogianni M, Liatis S, Grammatikou S, Perrea D, Katsilambros N, Makrilakis K, 2012 Changes in dietary habits and their association with metabolic markers after a non-intensive, community-based lifestyle intervention to prevent type 2 diabetes, in Greece. The DEPLAN study. Diabetes Res Clin Pract 95: 207-214.
26. Friedewald WT, Levy RI, Fredrickson DS, 1972 Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentifuge. Clin Chem 18: 499-502.
27. Lakka TA, Laaksonen DE, 2007 Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32: 76-88.
28. Pan XR, Li GW, Hu YH, et al, 1997 Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544.
29. Knowler WC, Barrett-Connor E, Fowler SE, et al, 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
30. The Diabetes Prevention Program, 1999 Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 22: 623-634.